amsacrine and netropsin

amsacrine has been researched along with netropsin in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's6 (85.71)18.2507
2000's1 (14.29)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bailly, C; Collyn-d'Hooghe, M; Colson, P; Fosse, P; Fournier, C; Hecquet, B; Hénichart, JP; Houssier, C; Lantoine, D; Saucier, JM1
Heimpel, S; Hiller, KH; Hoehn, H; Poot, M1
Bailly, C; Bourdouxhe, C; Colson, P; Denny, WA; Hénichart, JP; Houssier, C; Waring, MJ1
Auclair, C; Carteau, S; Goulaouic, H; Mouscadet, JF; Subra, F1
Bailly, C; Bourdouxhe-Housiaux, C; Colson, P; Houssier, C; Waring, MJ1
Bailly, C; Denny, WA; Henichart, JP; Riou, JF; Waring, MJ1
Herdewijn, P; Zhang, Z1

Other Studies

7 other study(ies) available for amsacrine and netropsin

ArticleYear
Biological activity and molecular interaction of a netropsin-acridine hybrid ligand with chromatin and topoisomerase II.
    Biochemical pharmacology, 1992, Feb-04, Volume: 43, Issue:3

    Topics: Amsacrine; Animals; Body Weight; Cell Division; Chromatin; DNA Damage; Drug Design; Female; Fluorouracil; Humans; Leukemia P388; Mice; Netropsin; Topoisomerase II Inhibitors; Tumor Cells, Cultured

1992
Distinct patterns of cell cycle disturbance elicited by compounds interfering with DNA topoisomerase I and II activity.
    Experimental cell research, 1995, Volume: 218, Issue:1

    Topics: Amsacrine; Bisbenzimidazole; Camptothecin; Cell Cycle; Cell Line; Distamycins; DNA; Dose-Response Relationship, Drug; Ethidium; Flow Cytometry; Humans; Intercalating Agents; Kinetics; Lymphocytes; Netropsin; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors

1995
Design of composite drug molecules: mutual effects on binding to DNA of an intercalator, amsacrine, and a minor groove binder, netropsin.
    Anti-cancer drug design, 1995, Volume: 10, Issue:2

    Topics: Amsacrine; Animals; Base Sequence; Binding Sites; Cattle; Circular Dichroism; DNA; Drug Design; Intercalating Agents; Molecular Sequence Data; Netropsin; Oligodeoxyribonucleotides; Spectrum Analysis

1995
Effect of topoisomerase inhibitors on the in vitro HIV DNA integration reaction.
    Biochemical and biophysical research communications, 1993, May-14, Volume: 192, Issue:3

    Topics: Amsacrine; Antineoplastic Agents; Antiviral Agents; Base Sequence; Camptothecin; Carbazoles; DNA Nucleotidyltransferases; Ellipticines; Escherichia coli; Etoposide; HIV Long Terminal Repeat; HIV-1; Integrases; Kinetics; Molecular Sequence Data; Netropsin; Oligodeoxyribonucleotides; Plasmids; Recombinant Proteins; Substrate Specificity; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors

1993
Interaction of a DNA-threading netropsin-amsacrine combilexin with DNA and chromatin.
    Biochemistry, 1996, Apr-09, Volume: 35, Issue:14

    Topics: Amsacrine; Animals; Base Sequence; Binding Sites; Cattle; Chromatin; Circular Dichroism; DNA; DNA Adducts; Drug Design; In Vitro Techniques; Intercalating Agents; Ligands; Models, Molecular; Molecular Sequence Data; Molecular Structure; Netropsin; Nucleic Acid Conformation

1996
Copper-dependent oxidative and topoisomerase II-mediated DNA cleavage by a netropsin/4'-(9-acridinylamino)methanesulfon-m-anisidide combilexin.
    Molecular pharmacology, 1997, Volume: 51, Issue:3

    Topics: Amsacrine; Antineoplastic Agents; Base Sequence; Copper; DNA; DNA Footprinting; DNA Topoisomerases, Type II; Intercalating Agents; Molecular Sequence Data; Netropsin; Oxidation-Reduction

1997
Selection of an unnatural peptide library for dsDNA binding.
    Current medicinal chemistry, 2001, Volume: 8, Issue:5

    Topics: Amino Acids; Amsacrine; Binding Sites; Chemistry, Pharmaceutical; Combinatorial Chemistry Techniques; DNA; Drug Design; Humans; Models, Molecular; Netropsin; Peptide Library

2001